Drug Database
Back to search

Czechia· CZ-0272319

NINTEDANIB ACCORD

A nintedanib product containing nintedanib esilate, registered in Czechia by Accord Healthcare S.L.U., Barcelona. The same ATC class is registered in 14 of our 19 countries.

ATC L01EX09

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedNINTEDANIB ACCORDATCL01EX09REGISTER NO.CZ-0272319PACKS LISTED0CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nintedanib esilateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nintedanib is registered in 14 of 19 countries.

Countries holding a registration under ATC L01EX09 (nintedanib), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose
Search nintedanib products by name

Nintedanib · ATC L01EX09

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nintedanib costs, country by country.

Normalised to the WHO defined daily dose (0.38 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Nintedanib · price per daily dose (0.38 g)

USD · FX 28 Sept 2026

  • CH Switzerland$34.12
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)
Active substance
NINTEDANIB ESILATE
Manufacturer
Accord Healthcare S.L.U., Barcelona
Country
Czechia (CZ)
ATC code
L01EX09
ATC class
Nintedanib
Defined daily dose
0.38 g, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

160 interactions on record for nintedanib.

Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nintedanib against other medicinesHow interaction checks work

Nintedanib · interactions on record

160 records

  • 21 severe
  • 139 moderate

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • DexamethasoneH02AB02severe
  • RifampicinJ04AB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nintedanib in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nintedanib products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Nintedanib Accordpharma, Nintedanib Ratiopharm
  • Cyprus · Nintedanib Teva
  • Germany · Nintedanib Al, Nintedanib Ipf Al
  • Denmark · Nintedanib Bioglan, Nintedanib Teva
  • Estonia · Nintedanib Stada
  • Finland · Bioglan, Nintedanib Bioglan
  • United Kingdom (Northern Ireland) · Nintedanib, Nintedanib Eugia (Uk)
  • Hungary · Lunidoc
  • Iceland · Nintedanib Demo
  • Luxembourg · Nintedanib Teva
  • Netherlands · Nintedanib Reig Jofre, Nintedanib Tillomed
  • Norway · Nintedanib Zentiva
  • Portugal · Nintedanib Bravet, Nintedanib Teva Pharma
  • Romania · Gevesla, Nintedanib Teva
  • Sweden · Nintedanib Bioglan, Nintedanib Teva Gmbh
  • Slovakia · Gevesla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d35ee2d3-eef1-4f25-8cb7-1fbc369bf879
GET /v1/drugs/d35ee2d3-eef1-4f25-8cb7-1fbc369bf879?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "CPS MOL",
  "source": "sukl",
  "strength": "100MG",
  "pack_size": "60X1",
  "substance": "NINTEDANIB ESILATE",
  "cz_kod_sukl": "0272319",
  "product_type": "CH",
  "substance_codes": "20446",
  "registration_state": "R",
  "registration_number": "EU/1/24/1803/005"
}
API referenceMCP serverPlans

See everything about nintedanib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console